Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Axela, a recognized innovator in protein interaction technology, has received patent for assays based on light diffraction technology from the US Patent and Trademark Office.
Subscribe to our email newsletter
Additionally the company has reported that it has changed its name from Axela Biosensors to Axela, to reflect the broad range of applications and markets served by its technology beyond traditional biosensing. Axela has established operations in a GMP/GLP facility in Foster City, California to accelerate the development of real time multiplex immunoassay kits for the dotLab System.
Rocky Ganske, CEO of Axela, said: “The issuance of this patent further reinforces the strong intellectual property position Axela has established in the use of diffractive optics to significantly improve the performance of immunoassays in research and diagnostic applications.”